Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
1.170
-0.110 (-8.59%)
Nov 10, 2025, 4:00 PM EST - Market closed

MTNB Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for MTNB in the last 12 months.

Price Target: n/a
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for MTNB.

Recommendation Trends

RatingMay '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy222220
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222220

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aOct 31, 2024
BTIG
BTIG
Strong Buy
Initiates
$150
Strong BuyInitiates$150+12,720.51%Oct 11, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$150
Strong BuyReiterates$150+12,720.51%Jan 31, 2023
Piper Sandler
Piper Sandler
Buy
Initiates
$150
BuyInitiates$150+12,720.51%Jan 27, 2020
SunTrust Robinson Humphrey
SunTrust Robinson Humphrey
Strong Buy
Initiates
$150
Strong BuyInitiates$150+12,720.51%Jan 24, 2020
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.53
from -4.98
EPS Next Year
-5.10
from -1.53
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
158.33K33.00K3.19M1.10M---
Revenue Growth
76.29%-79.16%9,560.61%-65.62%---
EPS
-5.90-5.63-4.84-5.28-4.98-1.53-5.10
EPS Growth
-------
Forward PE
-------
No. Analysts
-----34
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027
High--
Avg--
Low--

EPS Forecast

EPS202520262027
High-1.58-4.20
Avg-1.53-5.10
Low-1.47-5.88

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.